As an industry, biopharma actually fares pretty well when it comes to taxes. Among profitable companies, biotech and pharma have some of t...

What if they had a week and no biopharma deals happened? We’re not quite at that point but it has been slow-going, to put it mildly, on t...

When the Nasdaq’s biotech index topped 1,600 late last week, many people noted it was an all-time high, even higher than the 2000 bubble...

When it comes to corporate tax planning, biopharmas as a group aren’t spectacularly sophisticated. (A few exceptions come to mind, most no...